Evidence map›Paper›PMID 36944438›Full record

ArticleBMJ open gastroenterology2023

Evaluation of bowel preparation regimens for colonoscopy including a novel low volume regimen (Plenvu): CLEANSE study.

Ahmir Ahmad, Sarah Marshall, Paul Bassett, Kowshika Thiruvilangam, Angad Dhillon, Brian P Saunders

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in BMJ open gastroenterology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07215000 (Cleansing Options in Outpatient Setting to Improve Tolerance), which is not on this map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07215000 phase4recruitingnot on this mapstarted 2025, after this paper: background citation

Cleansing Options in Outpatient Setting to Improve Tolerance (COOP SIT) Trial

TypeinterventionalSponsorMorehouse School of MedicineRan2025 to 2027Enrolled300ConditionsColorectal Cancer Screening, Bowel Cleansing for ColonoscopyArmsGolytely, Sulfave, Sutab
3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Ahmir AhmadWolfson Unit for Endoscopy, St Mark's Hospital, London, UK ahmir.ahmad@nhs.net.ORCID 0000-0002-5779-3545
Sarah MarshallWolfson Unit for Endoscopy, St Mark's Hospital, London, UK.
Paul BassettStatsconsultancy Ltd, Amersham, UK.
Kowshika ThiruvilangamWolfson Unit for Endoscopy, St Mark's Hospital, London, UK.
Angad DhillonQueen Elizabeth Hospital, Lewisham and Greenwich NHS Trust, London, UK.
Brian P SaundersWolfson Unit for Endoscopy, St Mark's Hospital, London, UK.
St Mark's Hospital · GBQueen Elizabeth Hospital · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPoor bowel preparation is the leading cause of failed colonoscopies and increases costs significantly. Several, split preparation, 2 day regimens are available and recently, Plenvu, a low-volume preparation which can be given on 1 day has been introduced.

aimsAssess efficacy and tolerability of commonly used purgative regimens including Plenvu.

methodIn this service evaluation, patients undergoing screening colonoscopy at St Mark's Hospital, London (February 2020-December 2021) were provided Plenvu (1 or 2 days), Moviprep (2 days) or Senna & Citramag (2 days).Boston Bowel Preparation Scale (BBPS) score, fluid volumes and procedure times were recorded. A patient experience questionnaire evaluated taste, volume acceptability, completion and side effects.

results563 patients were invited to participate and 553 included: 218 Moviprep 2 days, 108 Senna & Citramag 2 days, 152 Plenvu 2 days and 75 Plenvu 1 day.BBPS scores were higher with Plenvu 1 and 2 days vs Senna & Citramag (p=0.003 and 0.002, respectively) and vs Moviprep (p=0.003 and 0.001, respectively). No other significant pairwise BBPS differences and no difference in preparation adequacy was seen between the groups.Patients rated taste as most pleasant with Senna & Citramag and this achieved significance versus Plenvu 1 day and 2 days (p=0.002 and p<0.001, respectively) and versus Moviprep (p=0.04).

conclusionBBPS score was higher for 1 day and 2 days Plenvu versus both Senna & Citramag and Moviprep. Taste was not highly rated for Plenvu but it appears to offer effective cleansing even when given as a same day preparation.

Indexed as

CatharticsColonoscopyPolyethylene GlycolsCitric AcidHumansOrganometallic CompoundsSenna ExtractSurveys and QuestionnairesTreatment OutcomeCatharticsCitric Acidmagnesium citrateMoviPrepOrganometallic CompoundsPolyethylene GlycolsSenna Extractcolonoscopydiagnostic and therapeutic endoscopyendoscopy

Identifiers

PMID36944438
PMCPMC10032399
OpenAlexW4353015049

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.